The MOH Deputy Minister for Executive Affairs Dr. Mansour Al-Hawasi has issued a generalization to all Director Generals for Health Affairs, whereby he ordered recalling of Isotrexin Gel pharmaceuticals from markets, including Batch No. 145J, Batch No. 187J, Batch No. 135J, and Batch No. 647J. The action follows a similar action taken by the Irish Stiefel Co., the original producer of Isotrexin preparations and distributor of the products in Saudi Arabia through the Saudi International Trading Co. Both actions have attributed recalling to the products failure in verification tests.